Dermata Therapeutics Inc. (DRMA) is preparing for its first OTC product launch in mid-2026, following a strategic shift from developing prescription dermatology products to focusing on an OTC pharmaceutical product line targeting multiple skin conditions.
The upcoming launch will feature the company's first once-weekly acne treatment kit, under its product line, named Tome, marking a significant step in its expansion into consumer dermatology.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.